Author

T. Bald

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

M. Braun· 2 shared A. C. Dudley· 1 shared A. Jakovija· 1 shared A. Kumar· 1 shared A. O. Yam· 1 shared A. Porter· 1 shared A. Rohani· 1 shared A. Song· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Braun

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Type I interferon drives a cellular state inert to TCR-stimulation and could impede effective T-cell differentiation in cancer

D. Corvino, M. Batstone, B. G. M. Hughes, T. Kempchen, S. S. Ng, N. Salim, F. Schneppenheim, D. Rommel, A. Kumar, S. Pearson, J. Madore, L. T. Koufariotis, L. M. Steinheuer, D. Pathirana, K. Thurley, , T. Bald

The paper identifies a subset of CD8+ TILs in HPV-HNSCC enriched for interferon-stimulated genes that are transcriptionally inert to TCR stimulation and may hinder T-cell differentiation.

bioRxiv · Mar 28, 2024Immunology

Oncogenic drivers dictate immune control of acute myeloid leukemia.

R. J. Austin, J. Straube, R. Halder, Y. Janardhanan, C. Bruedigam, M. Witkowski, L. Cooper, A. Porter, M. Braun, F. Souza-Fonseca-Guimaraes, S. A. Minnie, E. Cooper, S. Jacquelin, A. Song, T. Bald, , M. J. Bywater

This study shows that specific AML oncogenes influence immune responses and escape mechanisms, with NrasG12D promoting anti-leukemia immunity that can be counteracted by Myc.

bioRxiv · Feb 8, 2023Cancer Biology

Melanoma cells appropriate pericyte:endothelial cell crosstalk during perivascular invasion in the brain

Y. Zhang, C. P. Riedstra, S. Wang, S. Patel, T. Bald, P. Kumar, A. Rohani, D. F. Kashatus, S. J. Moschos, A. C. Dudley

This study identifies how melanoma cells use pericyte:endothelial cell signaling during brain invasion, showing that Sox9hi mesenchymal cells use Snail1-dependent mechanisms while Sox10hi cells form clusters.

bioRxiv · Jul 15, 2022 · PreprintCancer Biology

Microbial activation converts neutrophils into anti-tumor effectors

A. O. Yam, J. Bailey, F. Lin, A. Jakovija, C. Counoupas, J. A. Triccas, M. Gunzer, T. Bald, S. T. Grey, T. Chtanova

This study shows microbial bioparticles convert neutrophils into anti-tumor effectors by altering their phenotype and function, leading to tumor growth inhibition.

bioRxiv · Aug 21, 2020 · PreprintImmunology